Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor (OMI) delivers critical healthcare logistics solutions across 90+ countries, connecting medical manufacturers with care providers. This dedicated news hub provides verified updates on OMI's operational milestones, financial performance, and industry leadership in medical supply chain management.
Investors and healthcare professionals will find timely reports on earnings announcements, strategic partnerships, and innovations in patient direct services. Our curated collection includes press releases detailing supply chain advancements, product distribution expansions, and operational efficiency initiatives.
The page features essential updates across three key areas: quarterly financial results, major contract awards, and technological improvements in medical logistics. Users can track OMI's role in enhancing healthcare infrastructure through its dual focus on bulk institutional supply and direct-to-patient delivery networks.
Bookmark this resource for streamlined access to Owens & Minor's official communications. Regularly updated content ensures stakeholders maintain current awareness of developments impacting medical supply chain dynamics and healthcare delivery ecosystems.
Owens & Minor has commenced construction on a 350,000 sq. ft. center in Morgantown, West Virginia, set to open in late 2023. This facility will serve as a primary hub for medical supply logistics, enhancing healthcare resilience in the region. The project involves a $50 million investment and is expected to create over 100 jobs. This groundbreaking further solidifies the partnership between Owens & Minor and WVU Medicine, which aims to bolster response capabilities for public health emergencies.
Owens & Minor, Inc. (NYSE: OMI) has appointed Tammy Gomez as Executive Vice President & Chief Human Resources Officer effective July 11, 2022. Reporting to President and CEO Edward A. Pesicka, Gomez will lead the company's people strategy, focusing on talent retention, development, and engagement. She aims to enhance Owens & Minor’s culture and diversity initiatives. With over two decades of healthcare experience, including leadership roles at Cardinal Health, Gomez's appointment is expected to strengthen the company's workforce strategy.
Owens & Minor, Inc. (NYSE: OMI) announced the election of Rita Johnson-Mills and Terri Kline to its Board of Directors, effective June 1, 2022. Their extensive experience in healthcare is expected to enhance the Board's diversity and support long-term success. Johnson-Mills, with over 25 years in healthcare leadership, focuses on sustainable growth and employee engagement. Kline brings a robust background in various healthcare sectors, driving growth and M&A. Both leaders are poised to provide valuable insights for Owens & Minor's strategic direction.
Owens & Minor, Inc. (NYSE: OMI) has announced that its executive management team will present at the UBS Global Healthcare Conference on Monday, May 23rd at 11:30 AM ET. A live webcast and replay of the presentation will be available on their website in the investor relations section. With a history extending back to 1882, Owens & Minor is a global healthcare solutions company focused on product manufacturing and delivery, as well as home health supply services.
Owens & Minor, Inc. (NYSE: OMI) will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 10th at 10:00 AM PT. The chat features CEO Ed Pesicka and CFO Andy Long.
Investors can access a live webcast and replay via Owens & Minor's website. The company, headquartered in Richmond, VA, integrates healthcare solutions and has been operational since 1882, employing over 20,000 people globally.
Owens & Minor reported a strong Q1 2022 with revenue of $2.4 billion, a 3.5% increase from Q1 2021. Patient Direct segment revenue surged 25.7%, buoyed by the recent acquisition of Apria, which is expected to contribute significantly to future earnings. GAAP EPS was $0.52, while adjusted EPS reached $0.96. The company revised 2022 guidance upward, anticipating revenue between $9.9 billion and $10.3 billion and adjusted EBITDA of $580 million to $630 million, aided by $180 million from Apria. However, elective procedure volumes are projected to remain slightly below pre-pandemic levels.
Owens & Minor, Inc. (NYSE: OMI) will release its first quarter 2022 financial results after market close on May 3, 2022. A conference call for investors is scheduled for 4:30 p.m. ET the same day to discuss these results. Participants can join by calling 866-393-1604 or 1-224-357-2191 for international access. A replay will be available for one week. Owens & Minor is a global healthcare solutions provider, focusing on supply chain management and product manufacturing.
Owens & Minor has successfully completed its acquisition of Apria for approximately
Owens & Minor, Inc. (NYSE: OMI) has announced the upsize and pricing of its private offering of $600 million in senior notes, increasing the size by $100 million. The 6.625% notes due 2030 will close on March 29, 2022. Proceeds will finance the acquisition of Apria, Inc. and repay Apria's debt, with excess funds for corporate purposes. The notes are offered only to qualified institutional buyers and are not registered under the Securities Act.